CD177 antibody
Quick Overview for CD177 antibody (ABIN1837719)
Target
See all CD177 AntibodiesReactivity
Host
Clonality
Conjugate
Application
Clone
-
-
Specificity
- Cd177 (NP1), a glycosyl phosphatidylinositol (GPI) linked N glycosylated cell surface glycoprotein, was first described in a case of neonatal alloimmune neutropenia and analyses showed cell surface expression of a 60 kD protein, 14 kD greater than the predicted size, probably due to the presence of 3 potential N glycosylation sites. Immunohistochemistry demonstrated expression in bone marrow early erythroblasts, megakaryocytes, promyelocytes, and myelocytes. The neutrophil NB1 antigen (CD177) is expressed by 97 % of the Caucasian population. Antibodies against NB1 can be involved in neonatal alloimmune neutropenia (NAN).
-
Purification
- Purified
-
Immunogen
-
Human granulocytes.
Type of Immunogen: Cells -
Isotype
- IgG1
-
-
-
-
Application Notes
- Optimal working dilution should be determined by the investigator.
-
Comment
-
Target Species of Antibody: Human
-
Restrictions
- For Research Use only
-
-
-
Format
- Liquid
-
Concentration
- Lot specific
-
Buffer
- PBS, pH 7.4, 15 mM sodium azide
-
Preservative
- Sodium azide
-
Precaution of Use
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Storage
- 4 °C
-
Storage Comment
- Store at 4°C.
-
-
- CD177 (CD177 Molecule (CD177))
-
Alternative Name
- CD177
-
Background
-
Name/Gene ID: CD177
Synonyms: CD177, CD177 Molecule, CD177 antigen, Cell surface receptor, HNA-2a, HNA2A, NB1, PRV-1, Polycythemia rubra vera 1, PRV1, NB1 glycoprotein, NB1 GP -
Gene ID
- 57126
-
UniProt
- Q8N6Q3
Target
-